Literature DB >> 32504466

Automated Muscle Measurement on Chest CT Predicts All-Cause Mortality in Older Adults From the National Lung Screening Trial.

Leon Lenchik1, Ryan Barnard2, Robert D Boutin3, Stephen B Kritchevsky4, Haiying Chen2, Josh Tan1, Peggy M Cawthon5, Ashley A Weaver6, Fang-Chi Hsu2.   

Abstract

BACKGROUND: Muscle metrics derived from computed tomography (CT) are associated with adverse health events in older persons, but obtaining these metrics using current methods is not practical for large datasets. We developed a fully automated method for muscle measurement on CT images. This study aimed to determine the relationship between muscle measurements on CT with survival in a large multicenter trial of older adults.
METHOD: The relationship between baseline paraspinous skeletal muscle area (SMA) and skeletal muscle density (SMD) and survival over 6 years was determined in 6,803 men and 4,558 women (baseline age: 60-69 years) in the National Lung Screening Trial (NLST). The automated machine learning pipeline selected appropriate CT series, chose a single image at T12, and segmented left paraspinous muscle, recording cross-sectional area and density. Associations between SMA and SMD with all-cause mortality were determined using sex-stratified Cox proportional hazards models, adjusted for age, race, height, weight, pack-years of smoking, and presence of diabetes, chronic lung disease, cardiovascular disease, and cancer at enrollment.
RESULTS: After a mean 6.44 ± 1.06 years of follow-up, 635 (9.33%) men and 265 (5.81%) women died. In men, higher SMA and SMD were associated with a lower risk of all-cause mortality, in fully adjusted models. A one-unit standard deviation increase was associated with a hazard ratio (HR) = 0.85 (95% confidence interval [CI] = 0.79, 0.91; p < .001) for SMA and HR = 0.91 (95% CI = 0.84, 0.98; p = .012) for SMD. In women, the associations did not reach significance.
CONCLUSION: Higher paraspinous SMA and SMD, automatically derived from CT exams, were associated with better survival in a large multicenter cohort of community-dwelling older men. Published by Oxford University Press on behalf of The Gerontological Society of America 2020.

Entities:  

Keywords:  Computed tomography; Machine learning; Mortality; Myosteatosis; Sarcopenia

Mesh:

Year:  2021        PMID: 32504466      PMCID: PMC7812435          DOI: 10.1093/gerona/glaa141

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  61 in total

1.  Automated Segmentation of Tissues Using CT and MRI: A Systematic Review.

Authors:  Leon Lenchik; Laura Heacock; Ashley A Weaver; Robert D Boutin; Tessa S Cook; Jason Itri; Christopher G Filippi; Rao P Gullapalli; James Lee; Marianna Zagurovskaya; Tara Retson; Kendra Godwin; Joey Nicholson; Ponnada A Narayana
Journal:  Acad Radiol       Date:  2019-08-10       Impact factor: 3.173

2.  Transition to sarcopenia and determinants of transitions in older adults: a population-based study.

Authors:  Rachel A Murphy; Edward H Ip; Qiang Zhang; Robert M Boudreau; Peggy M Cawthon; Anne B Newman; Frances A Tylavsky; Marjolein Visser; Bret H Goodpaster; Tamara B Harris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-09-07       Impact factor: 6.053

3.  Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods.

Authors:  Caroline Chiles; Fenghai Duan; Gregory W Gladish; James G Ravenel; Scott G Baginski; Bradley S Snyder; Sarah DeMello; Stephanie S Desjardins; Reginald F Munden
Journal:  Radiology       Date:  2015-03-09       Impact factor: 11.105

4.  Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women.

Authors:  M Visser; D J Deeg; P Lips; T B Harris; L M Bouter
Journal:  J Am Geriatr Soc       Date:  2000-04       Impact factor: 5.562

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.

Authors:  Onno M Mets; Constantinus F M Buckens; Pieter Zanen; Ivana Isgum; Bram van Ginneken; Mathias Prokop; Hester A Gietema; Jan-Willem J Lammers; Rozemarijn Vliegenthart; Matthijs Oudkerk; Rob J van Klaveren; Harry J de Koning; Willem P Th M Mali; Pim A de Jong
Journal:  JAMA       Date:  2011-10-26       Impact factor: 56.272

7.  Computed tomography abbreviated assessment of sarcopenia following trauma: The CAAST measurement predicts 6-month mortality in older adult trauma patients.

Authors:  Christine M Leeper; Elizabeth Lin; Marcus Hoffman; Anisleidy Fombona; Tianhua Zhou; Matthew Kutcher; Matthew Rosengart; Gregory Watson; Timothy Billiar; Andrew Peitzman; Brian Zuckerbraun; Jason Sperry
Journal:  J Trauma Acute Care Surg       Date:  2016-05       Impact factor: 3.313

8.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

Review 9.  Radiologically Determined Sarcopenia Predicts Morbidity and Mortality Following Abdominal Surgery: A Systematic Review and Meta-Analysis.

Authors:  Keaton Jones; Alex Gordon-Weeks; Claire Coleman; Michael Silva
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

10.  Gender-Specific Associations between Low Skeletal Muscle Mass and Albuminuria in the Middle-Aged and Elderly Population.

Authors:  Hye Eun Yoon; Yunju Nam; Eunjin Kang; Hyeon Seok Hwang; Seok Joon Shin; Yeon Sik Hong; Kwi Young Kang
Journal:  Int J Med Sci       Date:  2017-09-03       Impact factor: 3.738

View more
  5 in total

1.  A Fully Automated Deep Learning Pipeline for Multi-Vertebral Level Quantification and Characterization of Muscle and Adipose Tissue on Chest CT Scans.

Authors:  Christopher P Bridge; Till D Best; Maria M Wrobel; J Peter Marquardt; Kirti Magudia; Cylen Javidan; Jonathan H Chung; Jayashree Kalpathy-Cramer; Katherine P Andriole; Florian J Fintelmann
Journal:  Radiol Artif Intell       Date:  2022-01-05

2.  Fully Automated Deep Learning Tool for Sarcopenia Assessment on CT: L1 Versus L3 Vertebral Level Muscle Measurements for Opportunistic Prediction of Adverse Clinical Outcomes.

Authors:  Perry J Pickhardt; Alberto A Perez; John W Garrett; Peter M Graffy; Ryan Zea; Ronald M Summers
Journal:  AJR Am J Roentgenol       Date:  2021-08-18       Impact factor: 6.582

3.  Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer.

Authors:  Ming Yang; Lingling Tan; Lingling Xie; Song Hu; Dan Liu; Jing Wang; Weimin Li
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

Review 4.  Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era.

Authors:  Annika Ritz; Eberhard Lurz; Michael Berger
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

5.  Chest computed tomography-derived muscle mass and quality indicators, in-hospital outcomes, and costs in older inpatients.

Authors:  Yanjiao Shen; Li Luo; Hongbo Fu; Lingling Xie; Wenyi Zhang; Jing Lu; Ming Yang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-17       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.